Overview

Effects of Maintaining Steady Albumin Levels (TAT 4) on Survival and Liver Related Complications in Cirrhosis With Ascites

Status:
Unknown status
Trial end date:
2021-08-08
Target enrollment:
Participant gender:
Summary
Investigators intend to assess the utility of regular albumin infusions to maintain a targeted serum albumin level of 4.0 g/dl in newly detected cirrhotic patients with low albumin levels (<2.8g/dl) with ascites.
Phase:
N/A
Details
Lead Sponsor:
Institute of Liver and Biliary Sciences, India